The purpose of this prospective study was to determine the results of percutaneous aortic balloon valvuloplasty as assessed by clinical evaluation and Doppler echocardiography.
For each patient, three initial inflations were performed with a 15-mm balloon. If the catheter-derived peak-to-peak gradient had not decreased by 50% or was more than 40 mm Hg, then additional inflations were performed with either a larger single balloon or dual balloons. The duration of each inflation was 1 minute unless there was hemodynamic compromise during the inflation, necessitating a shorter inflation duration. The inflations had to be terminated early in 30% of inflations with the larger single balloons (20 and 23 mm) or the dual balloons.
At the end of the procedure, repeat aortic valve areas were calculated. An aortic root angiogram was performed unless there was severe hemodynamic compromise or chronic renal failure present (52 patients). All patients were sent to the intensive care unit for 24-hour monitoring and then dismissed to a regular hospital floor bed.
Doppler Echocardiography
Cardiac catheterization has been the procedure of choice in the past for determination of aortic valve hemodynamics. However, the accuracy of Doppler echocardiography in assessment of aortic valve gradients and aortic valve area has recently been validated.8-13 Because Doppler echocardiography allows serial noninvasive measurements in this critically ill, elderly population, two-dimensional and Doppler echocardiograms were performed during three time periods: within 24 hours before the procedure, 24-48 hours after the procedure, and at later follow-up. From a two-dimensionally directed Mmode at midcavity level, an ejection fraction was calculated with a modification of the method described by Quinones et al. 14 A measurement of the left ventricular outflow tract diameter was obtained from a systolic two-dimensional freeze-frame in the parasternal long-axis view with the on-line measurement software package. The diameter was taken from the point of insertion of the aortic valve cusps into the aortic anulus. A left ventricular outflow tract velocity was measured by pulsed-wave Doppler echocardiography from the apical position, placing the sample volume in the left ventricular outflow tract just proximal to the region of high-velocity turbulence through the aortic valve. A nonimaging, continuous-wave probe was used to measure the velocity across the aortic valve. Multiple transducer positions were used to find the highest velocity jet, as described previously. 13, 15 For each time period, the signals with the highest velocity and well-defined spectral envelope were taken. The studies in which the spectral envelope was not well defined were excluded from analysis.
In patients with atrial fibrillation (10 patients), an average of 10 beats was used. The aortic valve velocity curve was digitized onto an off-line computer system for calculation of the mean aortic valve gradient, as previously described. ' 
Statistics
Changes in hemodynamic variables were tested studies were performed at the time of cardiac catheterization. The remaining 26 Doppler echocardiographic studies were done within 24 hours before the procedure. Figure 3 (right) demonstrates the aortic valve area by catheterization versus Doppler echocardiography after the procedure. The catheterization data were obtained immediately after the procedure, and the Doppler echocardiographic studies were performed 24-48 hours after the procedure.
In-Hospital Course There were five patients who required vascular surgery during the hospital stay for the development of a hematoma or pseudoaneurysm. Another nine patients developed large hematomas but did not require surgery. One patient developed a lowgrade fever and had a Gram-negative bacillus cultured from his blood. After treatment with intravenous antibiotics, there was no further evidence of infection. There were two patients who underwent aortic valve operation during the hospitalization, one because of inadequate hemodynamic results and the other because of continued symptoms of heart failure. One of these patients died after surgery because of cerebral anoxia from the operation.
There were two more deaths during the first 30 days after the procedure. One 77-year-old woman fell 1 week after the procedure and became bedridden because of a hip fracture. She subsequently developed a large cerebrovascular accident and died several days later. A second patient died suddenly while undergoing a bowel preparation for an abdominal operation several weeks later.
All five patients who survived to undergo noncardiac surgery did well during their respective opera- tions. There were no episodes of hemodynamic compromise or pulmonary edema during or after surgery.
Follow-up
Follow-up was obtained on all 50 remaining patients (100%). There were eight deaths in the follow-up period (Table 3) . Five deaths were because of progressive congestive heart failure at 2 (three patients), 4, and 5 months. One death was believed to be of a noncardiac etiology. This was in an 89-year-old man who developed severe depression and progressive lethargy without evidence of cardiac decompensation. There were two patients who had a change in mental status after the procedure. One of the patients had a new homonymous hemianopsia, but there were no other focal deficits. The other patient was found to have no focal neurological deficits. However, each patient experienced a progressive downhill course with mental deterioration and return of heart failure, eventually dying at 1 and 5 months, respectively, after the procedure. Of the seven patients who died with congestive heart failure, all were in New York Heart Association functional Class III or IV before the procedure, and five of seven had an ejection fraction equal to or less than 35%. All seven patients died before a repeat Doppler echocardiographic examination could be performed. The mean follow-up period ofthe surviving 42 patients was 6.2 months.
Initial subjective clinical improvement was noted by all patients. However, symptoms were noted to return in many patients by the time of follow-up. Figure 4 demonstrates the symptomatic status of the 50 patients at the time of follow-up or immediately before death. Of 38 patients (76%) who initially were severely symptomatic with heart failure symptoms or angina (New York Heart Association functional Class III or IV), 20 patients had sustained, significant relief of symptoms. However, 18 patients with transient improvement returned to their previous functional class, and one patient who was mildly symptomatic before the procedure was severely symptomatic at follow-up. Therefore, a total of 19 patients (38%) had New York Heart Association functional Class III or IV symptoms at follow-up. There were 11 patients who had experienced near-syncope or syncope before the procedure, and one patient with near-syncope during the follow-up period.
Seven patients underwent subsequent aortic valve replacement. Four were because of stenosis and recurrence of symptoms. Three patients underwent aortic valve replacement because of inadequate hemodynamic results, although they had remained free of significant symptoms by the time of operation. One of these three patients required concurrent vascular operation for the late occurrence of bilateral hematomas. There were no deaths during surgery.
A repeat balloon valvuloplasty was performed in four patients at 5.0, 6.5, 7.0, and 10.5 months, respectively, because of severe, recurrent heart failure. All four patients had experienced initial relief of symptoms. One patient died suddenly 4 days after the second valvuloplasty from hyperka- 
Class (11) Class (20) X (1) (38) lemia. Two patients have had sustained improvement of symptoms l and 2 months, respectively, later, but the third patient has developed severe heart failure 4 months after the procedure. Doppler echocardiographic data at follow-up was available in 35 patients. The aortic valve mean gradient was 46 ± 16 mm Hg, the peak left ventricular outflow velocity was 0.89 ± 0.21 m/sec, and the aortic valve area was 0.67±0.19 cm2. In the 30 patients who had complete hemodynamic data before valvuloplasty, 24-48 hours after the procedure, and at follow-up, there was a significant difference in the mean aortic valve gradients and aortic valve areas over these three time periods. All three time periods were significantly different for these two variables (p<0.05, Student-Newman-Keuls test). The aortic valve mean gradient at follow-up was significantly higher than hours after the procedure but lower than before the procedure (Figure 1) . The aortic valve area at follow-up was significantly lower than hours after the procedure but higher than before the procedure (Figure 2) . The peak left ventricular outflow velocity at follow-up was not significantly different than either before the procedure or 24-48 hours after the procedure.
Restenosis was diagnosed in 19 patients (63% of those who had complete hemodynamic information at all three time periods). In evaluating the subgroup of patients with mild or no symptoms of angina or heart failure at follow-up (New York Heart Association functional Class I or II), there were nine patients (47%) who met the criteria for restenosis.
The overall results of the outcome of patients with percutaneous aortic balloon valvuloplasty are shown in Figure 5 . Of the initial 55 patients, there were a total of 11 deaths (20% mortality). Nine patients underwent subsequent aortic valve replacement, and four had repeat valvuloplasty. In the remaining 31 [19] [20] [21] [25] [26] [27] The mortality and morbidity in this group of patients, however, should not be compared with previous surgical literature. Because of the highly selective inclusion criteria in this study, the majority of patients were more critically ill at presentation than in any comparable surgical series. 
